« Back to Record
Citation APA

La Rosée, P., Klag, T., Schenk, T., Hochhaus, A., Martiat, P., Leitner, A., Muller, M. M., Erben, P., & Saussele, S. (2013). Improved tolerability by a modified intermittent treatment schedule of dasatinib for patients with chronic myeloid leukemia resistant or intolerant to imatinib. Annals of hematology, 92(10), 1345-1350. doi:10.1007/s00277-013-1769-2


Permalink

http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/183104

La Rosée, P., Klag, T., Schenk, T., Hochhaus, A., Martiat, P., Leitner, A., Muller, M. M., Erben, P., & Saussele, S. (2013). Improved tolerability by a modified intermittent treatment schedule of dasatinib for patients with chronic myeloid leukemia resistant or intolerant to imatinib. Annals of hematology, 92(10), 1345-1350. doi:10.1007/s00277-013-1769-2